(Q34570034)

3 August 2017

1 reference

title

Lymph-node metastases in patients with melanoma: what is the optimum management? (English)

1 reference

3 August 2017

0 references

K Fife

1

1 reference

3 August 2017

J F Thompson

series ordinal

2

1 reference

3 August 2017

publication date

1 October 2001

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

614-621

1 reference

Technical details of intraoperative lymphatic mapping for early stage melanoma

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Morbidity, mortality and local recurrence following regional node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Axillary node dissection in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Loco-regional nodal relapse in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Experience with 998 cutaneous melanomas of the head and neck over 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Neck dissection for cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Cutaneous melanoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Malignant melanoma--introduction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

The argument against sentinel node biopsy for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

The radiosensitivity of melanoma cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

The optimal radiation dose per fraction for the treatment of malignant melanomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Fraction size in external beam radiation therapy in the treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Radical, modified, and selective neck dissection for cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Nodal radiation therapy for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Locally advanced melanoma: results of postoperative hypofractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Radiation therapy for nodal disease in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

0-7-21 radiotherapy in nodular melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2801%2900519-8

7 January 2021

10.1016/S1470-2045(01)00519-8

Identifiers

DOI

1 reference

3 August 2017

1 reference